Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation.

Christelle Ferra CollMireia Morgades de la FeLaura Prieto GarcíaCarlos Pinho VazMaría Inmaculada Heras FernandoRebeca Bailen AlmoroxGarcía-Cadenas IreneMarisa Calabuig MuñozTeresa Zudaire RipaJoud Zanabili Al-SibaiSandra NovoaBeatriz Aguado BuenoAnna Torrent CatarineuOriana López-GodinoRodrigo Martino BofarullMi KwonAntonio Campos JúniorDolores Caballero BarrigónJosep-Maria Ribera Santasusana

Published in: European journal of haematology (2023)

Despite the poor prognosis of patients with ALL presenting relapse after a first allo-SCT, some can be satisfactorily rescued and a second allo-SCT still remains a valid option for selected patients. Moreover, emerging therapies really might improve ALL patients outcome when relapsing after an allo-SCT .

Keyphrases

stem cell transplantation
poor prognosis
end stage renal disease
multiple sclerosis
newly diagnosed
ejection fraction
chronic kidney disease
high dose
prognostic factors
long non coding rna
peritoneal dialysis